|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/107 | |
| A61K 9/48 | |||
| A61K 31/568 | |||
| A61K 47/12 | |||
| A61K 47/14 | |||
| A61K 47/44 |
| (11) | Number of the document | 2803350 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14179390.1 |
| Date of filing the European patent application | 2010-04-12 | |
| (97) | Date of publication of the European application | 2014-11-19 |
| (45) | Date of publication and mention of the grant of the patent | 2017-09-20 |
| (46) | Date of publication of the claims translation |
| (72) |
Dudley, Robert, E., US
Constantinides, Panayiotis, P., US
|
| (73) |
Clarus Therapeutics, Inc.,
555 Skokie Boulevard, Suite 340, Northbrook, IL 60062,
US
|
| (54) | Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |
| Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |